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Bacteriophages that infect Gram-negative bacteria often bind to the bacterial surface
by interaction of specific proteins with lipopolysaccharide (LPS). Short tail fiber proteins
(tail adhesin, gp12) mediate adsorption of T4-like bacteriophages to Escherichia coli,
binding surface proteins or LPS. Produced as a recombinant protein, gp12 retains its
ability to bind LPS. Since LPS is able to exert a major impact on the immune response in
animals and in humans, we have tested LPS-binding phage protein gp12 as a potential
modulator of the LPS-induced immune response. We have produced tail adhesin gp12
in a bacterial expression system and confirmed its ability to form trimers and to bind LPS
in vitro by dynamic light scattering. This product had no negative effect on mammalian
cell proliferation in vitro. Further, no harmful effects of this protein were observed in mice.
Thus, gp12 was used in combination with LPS in a murine model, and it decreased the
inflammatory response to LPS in vivo, as assessed by serum levels of cytokines IL-
1 alpha and IL-6 and by histopathological analysis of spleen, liver, kidney and lungs.
Thus, in future studies gp12 may be considered as a potential tool for modulating and
specifically for counteracting LPS-related physiological effects in vivo.
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INTRODUCTION
Bacteriophages that infect Gram-negative bacteria often bind to lipopolysaccharide (LPS)
molecules exposed on the surface of the outer membrane. For this action bacteriophages use
dedicated attachment proteins. T4-like bacteriophages adsorb to Escherichia coli cells by two types
of specialized adhesion proteins: long tail fibers and short tail fibers. These two types of adhesins
differ in their role during phage infection of bacteria, and thus they differ in the affinity to LPS.
Long tail fibers consist of a few proteins that build an elongated flexible structure in which gp37
determines the affinity. Since the role of long tail fiber is “the first screening” and discrimination
between susceptible and non-susceptible bacteria, its binding to bacterial receptors is reversible.
Short tail fibers are known to bind LPS very firmly since their role is to anchor the phage to a host
selected by long tail fibers; they assure a fixed structure during penetration of the bacterial envelope
by the tail tube (Miroshnikov et al., 1998; van Raaij et al., 2001a,b; Thomassen et al., 2003).
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Short tail fibers of bacteriophage T4 consist of one type of
protein, gp12, that forms parallel homo-trimers. These homo-
trimers attach to the phage baseplate by the N-terminus while
the C-terminus functions as the LPS-binding site (van Raaij
et al., 2001a,b; Thomassen et al., 2003). In the phage particle,
spatial exposure of gp12 depends on the stage of infection:
its LPS-binding region is initially hidden in the baseplate. To
expose the LPS-binding region, another structural protein of
the phage, gp10, functions as a molecular lever that rotates and
extends the hinged short tail fibers, thus facilitating bacterial
cell attachment. All six short fibers turn to a perpendicular
position that allows for firm binding to LPS molecules (Leiman
et al., 2006). Interestingly, isolated gp12, that is expressed as
a recombinant protein, retains its ability to bind LPS (van
Raaij et al., 2001a,b; Thomassen et al., 2003). This feature has
already allowed for practical application of gp12 as an LPS ligand
in vitro: it serves as a reactant in LPS-removal and LPS-detection
kits1.
Lipopolysaccharides, also called endotoxins, are able to
exert a major impact on the immune response in animals
and in humans. LPS is the prototypical pathogen-associated
molecular pattern (PAMP); when detected in a living system,
LPS triggers a non-specific activation. LPS is recognized by
Toll-like receptors (TLRs) and other pattern recognition
receptors (PRRs) in both plants and animals (Poltorak et al.,
1998; Alexander and Rietschel, 2001; Medzhitov, 2007).
TLR4 is present on the surface of monocytes/macrophages,
neutrophils, myeloid dendritic cells, mast cells, B lymphocytes,
and intestinal epithelium (Sallusto and Lanzavecchia, 2002;
Sabroe et al., 2005; Gerondakis et al., 2007). Recognition and
immunostimulation by LPS is initialized by the combined
extracellular actions of LPS binding protein (LBP), TLR4,
MD-2 and CD14 the membrane-bound or soluble forms.
The key step is formation of the TLR4-MD-2-LPS complex.
This results in the rapid activation of intracellular signaling
pathways that are highly similar to the signaling systems
of IL-1 and IL-18 (Alexander and Rietschel, 2001). At the
systemic level, this reaction means an acute inflammatory
response, and it can be a key factor in sepsis and septic
shock.
At the same time, effects of bacteriophages on functions of the
immune system are gaining increasing interest in the scientific
community (Górski et al., 2006, 2012; Łusiak-Szelachowska et al.,
2014; Park et al., 2014; Hodyra-Stefaniak et al., 2015). This
interest results from safety issues related to practical applications
of bacteriophages, but also from the fact that bacteriophages
have the intrinsic ability to interact with bacterial products
such as LPSs and surface proteins. This ability is mediated
by specific phage proteins. Therefore, here we assess LPS-
binding phage protein gp12 as a potential modulator of the
LPS-induced immune response. This assessment involved initial
toxicity testing in cell cultures, and gp12 was further tested
for its ability to interfere with LPS-induced immunostimulation
in vivo.
1http://www.hyglos.de/en/products-services/products/endotoxin-removal.html
(accessed December 6, 2015).
MATERIALS AND METHODS
Construction of Expression Vector
Genes encoding short tail fiber (12) and its chaperone gp57
(57) were cloned to the expression plasmid pCDF-Duet1
(Streptomycin resistance; Novagen, USA), which contains two
multiple cloning sites (MCS) under a T7lac promoter control.
Amplification of gene 12 was conducted using polymerase
chain reaction (PCR) and T4 total DNA (Miernikiewicz
et al., 2012) as a template. The primers were 12 forward
5′-AAAAGGATCCGATGAGTAATAATACATATCAACACG-3′
and 12 reverse 5′-AAAGCGGCCGCTCATTCTTTTACCTTAAT
TATG-3′. The 12 gene was inserted into the first multiple cloning
site (MCS1) of pCDF-Duet1 via BamHI and NotI restriction
enzymes (restriction sites are underlined in primer sequences),
yielding pCDFg12. Then, the 57 gene was cloned into MCS2 of
pCDF-Duet1 by the GeneArt Gene Synthesis system (GeneArt,
Thermo Fisher Scientific, Poland), yielding pCDFg12g57.
All sequences were verified by automated Sanger sequencing
(Genomed, Poland). The obtained vector pCDFg12g57 expresses
gp12 with an N-terminal His-Tag and gp57 without any tags.
Expression and Purification of gp12
The pCDFg12g57 vector was expressed in a bacterial expression
system. E. coli strain B834(DE3) F- ompT hsdSB (r−B m
−
B )
gal dcm met (DE3; EMD, Europe) carrying pCDFg12g57 was
grown in Luria-Bertani Broth (LB) high salt (10 g/l of NaCl)
culture medium (Sigma-Aldrich, Europe or AppliChem, Europe)
supplemented with streptomycin at 37◦C until OD600 reached
0.8. Then, the bacterial culture was cooled down to 18◦C, induced
by 0.1 mM isopropyl thio-β-D-galactoside (IPTG) and further
incubated overnight at 18◦C.
Harvested bacteria were suspended in phosphate buffer
(50 mM Na2HPO4, 300 mM NaCl, pH 8), treated with PMSF
(1 mM) and incubated on ice for 15 min. The lysis was
done by incubation with lysozyme (0.5 mg/ml) for 6–7 h on
ice and by the freeze-thaw method (−80◦C). The preparation
was then supplemented with Mg2+ (up to 0.25 mM), DNase
(10 µg/ml) and RNase (20 µg/ml), and incubated on ice for
3 h. Fractions were separated by several centrifugations (12
000 rpm, 45 min, 15◦C). Soluble fractions were removed while
insoluble fractions were suspended in Tris buffer (40 mM Tris–
HCl pH 8, 10 mM EDTA) after each centrifugation, and gently
mixed for 30 min. The procedure was repeated three times.
The last pellets were suspended in phosphate buffer (50 mM
Na2HPO4, 300 mM NaCl, pH 8) and centrifuged in the same
conditions as mentioned above. Obtained soluble fractions were
filtered through 0.45 µm PVDF filters and further incubated
overnight at 10◦C with 1 % w/v glycerol. Next, the preparation
was supplemented with 25 mM imidazole and incubated with
NiNTA agarose (Qiagen, Germany) at room temperature for
2–3 h. The slurry was washed with 5 L of wash buffer I
(50 mM NaH2PO4 × H2O, 300 mM NaCl, 25 mM imidazole,
1% glycerol (w/v), 0.05% TWEEN (v/v), pH 8) and then with
5 L of wash buffer II (50 mM NaH2PO4 x H2O, 300 mM
NaCl, 25 mM imidazole, 1% glycerol (w/v)). These two steps
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of washing were conducted with very slow flow, about 200 ml
per hour. The last washing step was done with 100 ml of wash
buffer III (50 mM NaH2PO4 x H2O, 300 mM NaCl, 100 mM
imidazole, 1% glycerol (w/v)). Protein preparations were released
from the column using 5–6 sets of 5 ml of elution buffer
(50 mM NaH2PO4 x H2O, 300 mM NaCl, 500 mM imidazole,
4% glycerol (w/v)). The whole process was monitored by SDS-
PAGE. Elutions were combined according to their purity and
concentrated 2–5 times on Vivaspin centrifuge concentrators
(Sartorius, Poland) at 18–20◦C. Next, LPS was removed using
EndoTrap Blue (Miernikiewicz et al., 2012). The final preparation
was dialyzed against PBS at room temperature and filtered
through 0.22 µm PVDF filters. Its concentration was determined
by Lowry assay. Endotoxin level of the purified gp12 was assessed
using the EndoLisa Endotoxin Detection kit (Da˛browska et al.,
2014).
Particle Size Distribution
Lipopolysaccharide was isolated from E. coli liquid cultures
as described (Miernikiewicz et al., 2013). It was diluted with
deionized water and dispersed in an ultrasonic bath. Dispersion
(homogeneity) was controlled by particle size distribution
measurement; particle size distribution was analyzed by the
dynamic light scattering (DLS) method using Malvern Zetasizer
NanoZS (Malvern Instruments, UK). The same system was used
for detection of LPS-gp12 interactions: particle size distribution
was measured in solutions gp12 (10 µg/ml), LPS (10 µg/ml) or a
mixture of gp12 (10µg/ml) and LPS (10µg/ml). All samples were
diluted with deionized water and offset for 1 min prior to each
measurement. Albumin was used as a control. All experiments
were done at 25◦C. The measurements were repeated five times.
Cytotoxicity
The influence of gp12 on growth and viability of murine
and human cells was investigated. Tests were done on
murine fibroblasts (Balb3T3) and on human skin microvascular
endothelial cells (HSkMEC). Cells (104 cells/well) were grown
in 96-well plates for 24 h at 37◦C, 5% CO2. Then, cells
were supplemented with various concentrations of gp12 (1,
10, 100 µg/ml) and incubated for 72 h. PBS treated cells
served as a normal cell growth control (solvent control).
Next, the sulforhodamine B (SRB) test was done. Briefly,
50 µl of 50% trichloroacetic acid was added to each well
and incubated for 1 h at 4◦C. Then, plates were washed five
times with H2O, treated with 50 µl of 0.4% sulforhodamine
and incubated for 30 min at room temperature. 1% acetic
acid was used to wash plates and 10 nM Tris to dissolve
precipitated sulforhodamine. Measurement of cell viability was
done at 540 nm using a microplate reader (Gen5, Data Analysis
Software).
Animal Model
All animal experiments were performed according to EU
Directive 2010/63/EU for animal experimentations and were
approved by the 1st Local Committee for Experiments with
the Use of Laboratory Animals, Wrocław, Poland. The female
C57Bl6/J (6–10 weeks) mice were purchased from the Center of
FIGURE 1 | SDS-PAGE of: (A) expressed recombinant His-tagged gp12 and
gp57; overexpressed proteins are marked with arrows; M-molecular weight
marker; 1-soluble fraction of the culture before induction (control); 2-soluble
fraction of the culture after induction (expression); 3-insoluble fraction of the
culture before induction (control); 4-insoluble fraction of the culture after
induction (expression). (B) gp12 final preparation as trimeric and monomeric;
M – molecular weight marker; 1 – heated gp12 (denatured protein) as
monomeric (57.5 kDa); 2 – non-heated gp12 as trimeric (172.5 kDa).
FIGURE 2 | Binding of gp12 to lipopolysaccharide in vitro over time.
Binding was identified as changes in average particle size in solution by the
dynamic light scattering (DLS) method using Malvern Zetasizer NanoZS
(Malvern Instruments, UK). All samples were diluted with deionized water, and
size distribution was measured at 25◦C.
Experimental Medicine, Medical University of Białystok, Poland,
and bred under specific pathogen free (SPF) conditions in the
Animal Breeding Center of the Institute of Immunology and
Experimental Therapy (IIET).
Female C57Bl6/J mice (N = 6) were injected intraperitoneally
with 100 µg/mouse of gp12, 1 mg/kg of LPS or 100 µg/mouse
of gp12 simultaneously with 1 mg/kg of LPS. Control
mice were inoculated with PBS. After 3 and 7 h murine
blood was collected from the tail vein, whilst after 24 h
murine blood was collected from the orbital plexus vein
into heparinized tubes. All bleeding procedures were done
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FIGURE 3 | Proliferation of gp12-treated mammalian cells in vitro. (A) Murine fibroblasts (BALB/3T3) treated with 1, 10, or 100 µg/ml of gp12 for 72 h. PBS
served as a control. (B) Human skin microvascular endothelial cells (HSkMEC) treated with 1, 10, or 100 µg/ml of gp12 for 72 h. PBS served as a control.
under anesthesia. Serum was separated from the blood by
double centrifugation at 2250 × g and used for the ELISA
assay. Then animals were sacrificed by cervical dislocation
and the following organs were excised, for histopathological
examination: lungs, liver, spleen, and kidneys. All experiments
were repeated three times. A representative experiment is
presented.
Cytokine Assay
The progress of the inflammatory reaction in the murine blood
was monitored. Concentrations of IL-1α and IL-6 were measured
by commercially available ELISA kits (PeproTech). Mean values
per group of animals are presented.
Histopathology
For histopathological examination, the murine organs (lungs,
liver, spleen, and kidneys) were fixed in 7% formaldehyde for 48 h.
Later, samples were embedded in paraffin blocks. Histological
slides of 4 µm thickness were prepared and counterstained with
hematoxylin and eosin (HE), and examined microscopically. All
sections were analyzed by researchers blind to the experimental
groups of the samples.
Statistics
Statistical analysis was done by ANOVA, the Kruskal–Wallis test
and ANOVA with Bonferroni and Holm multiple comparison
calculation, with significance level p = 0.05. The Statistica 8.0
software package was applied (StatSoft, Inc. STATISTICA data
analysis software system, version 8.0)2.
2StatSoft, Inc: STATISTICA (data analysis software system), version 8.0. Available
at: http://www.statsoft.com (accessed April 20, 2015).
RESULTS
Expression and Purification of gp12
The short tail fibers of bacteriophage T4 are well known for their
LPS binding capability. This ability depends, however, on correct
gp12 quaternary structure meaning that phage adhesin has to
form its trimeric structure to be able to bind LPS. Proper folding
of gp12 was reported only in the presence of another T4 phage
protein, gp57. Its function as a molecular chaperone cannot be
substituted by host protein overexpression, e.g., GroEL/ES. Gp57
increases folding efficacy and production efficiency of gp12, and it
concurrently inhibits insoluble aggregate formation by this phage
adhesin (Burda and Miller, 1999). Thus, we cloned genes 12 and
57 of T4 phage to pCDF-Duet1, the expression vector that enables
simultaneous production of two proteins in bacterial expression
systems (Figure 1A).
Co-expression of gp12 with its natural chaperonin gp57
resulted in proper trimeric structure of the obtained product
as verified by SDS-PAGE. Verification was done according to
King and Laemmli (1971), who demonstrated that properly
folded, trimeric gp12 resisted dissociation by SDS at ambient
temperature, whereas heating caused monomerization of the
polypeptide chains (King and Laemmli, 1971). The molecular
weight of trimeric gp12 is 172.5 kDa, while that of monomeric
gp12 is 57.5 (Figure 1B).
Binding of gp12 to Lipopolysaccharide In
Vitro
The ability of purified recombinant gp12 to bind LPS was tested
in vitro by particle size distribution measurement in LPS solution.
This method employed DLS, and it allowed for detection of
a relative increase in average size of aggregating molecules in
solutions. Purified gp12 solution as well as LPS solution was
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FIGURE 4 | Effect of phage protein gp12 on: (A) IL-1α concentration in mice 3 h after treatment. (B) IL-1α concentration in mice 7 h after treatment; (C) IL-6
concentration in mice 3 h after treatment; (D) IL-6 concentration in mice 7 h after treatment. ∗p = 0.05.
dominated by small molecules, 51 nm and 95.45 nm, respectively;
these values were stable in time. However, after mixing gp12
with LPS the average size of molecules in the solution markedly
increased to 1980 nm (Figure 2). These results suggest that
recombinant gp12 was able to bind and form complexes with
LPS. Formation of these complexes was clearly visible within a
few minutes, and it seemed to be stabilized after approximately
45 min, with the average diameter of complexes being approx.
2000 nm (Figure 2).
Safety Testing of gp12 on Cell In Vitro
Cultures
Recombinant gp12, intended for in vivo application, was first
tested on mammalian cell lines in vitro to exclude its direct
toxic effects on cells. Potential harmful effects were assessed
in a proliferation assay on murine fibroblasts (BALB/3T3) and
HSkMEC. Both cell lines were treated with gp12 in cultures
(doses: 100, 10, or 1 µg of the tested protein per ml). After 72 h
of incubation, cell viability was assessed by the SRB method. No
toxic or antiproliferative effects of gp12 were detected in the cells
(Figures 3A,B).
Effect of gp12 on LPS-Induced
Inflammation In Vivo
The effect of gp12 on LPS-induced inflammation in vivo was
investigated in mice by comparison of serum inflammatory
markers (cytokines). Cytokines that are typical markers of
inflammation induced by LPS are IL-1α and IL-6. Here we
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FIGURE 5 | Histopathological examination of selected animal tissues. (A) lungs; (B) liver; (C) kidneys; (D) spleen.
compared IL-1α and IL-6 in mice treated with LPS (1 mg/kg)
or with purified gp12 (100 µg/mouse) or treated both with LPS
(1 mg/kg) and purified gp12 (100 µg/mouse). Control mice were
treated with PBS.
Immediate application of gp12 to mice challenged with LPS
resulted in a small reduction of serum IL-1α 3 h after the
treatment (27% reduction, insignificant) and in a substantial
reduction 7 h after the treatment: 72% (p = 0.002). In this
case, the serum level of IL-1α in mice challenged with LPS
and treated with gp12 was similar to that observed in control
mice (Figures 4A,B). The second marker of inflammation, IL-
6, was also reduced in LPS-challenged mice treated with gp12
(in comparison to non-treated animals). This reduction was 48%
(p = 0.001) 3 h after the treatment; however, no important effect
was observed 7 h after the treatment (Figures 4C,D). 24 h after
the challenge with LPS no significant differences were noted,
while serum levels of the tested cytokines were normalized after
that time (data not shown). Importantly, in mice treated with
gp12 alone no pro-inflammatory activity of this protein was
observed and no visible adverse effects of the treatment were
noted in these animals (Figure 4).
Further, leukocyte infiltration into selected tissues was
examined in these animals by histological microscopy (24 h
after the induction). As presented in Figure 5, infiltration of
leukocytes to lungs, liver and spleen was markedly increased
in mice treated with LPS when compared to control (PBS
treated) mice, which indicated an inflammatory reaction of the
immune system. However, in mice treated with recombinant
gp12 immediately after LPS injection, leukocyte infiltration in
the investigated tissues was minor (Figure 5). Gp12 significantly
decreased inflammatory infiltrate induced by LPS in liver and
spleen (Figure 5). No harmful effects of gp12 was observed
in tissues of mice treated with gp12 alone. These observations
suggest that gp12 may counteract the pro-inflammatory effect of
LPS in vivo.
DISCUSSION
Bacteriophage T4 tail adhesin gp12 was produced in native
conformation as a recombinant protein in a bacterial expression
system with the chaperone gp57. Similarly to its natural
prototype, this protein was able to form trimers and to bind LPS
in vitro, as shown by DLS (Figure 2). Such a product was not
harmful for cell proliferation in cell cultures in vitro, nor were
there any evident harmful effects on living mice (100 µg/mouse).
It was further used in combination with LPS in a murine model to
assess whether binding of gp12 to LPS might decrease the ability
of LPS to induce inflammation in vivo. As revealed by serum
cytokine assay and by examination of leukocyte infiltration into
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spleen, liver, kidney, and lungs, gp12 was able to counteract the
inflammatory response to LPS in vivo.
LPS consists of a poly- or oligosaccharide region that
is anchored in the outer bacterial membrane by a specific
carbohydrate lipid moiety termed lipid A. The lipid A component
is commonly considered as the primary immunostimulatory
center of LPS (Alexander and Rietschel, 2001) while phage short
tail fibers bind to the core region of LPS (van Raaij et al.,
2001a,b). However, immunoactivation by LPS in mammalian
systems depend on the LPS form. One can find “classical”
strongly agonistic (highly endotoxic) forms of LPS, but several
have been identified that display comparatively low or even
no immunostimulation for a given mammalian species. Some
members of the latter more heterogeneous group are capable of
antagonizing the effects of strongly stimulatory LPS/lipid A forms
(Alexander and Rietschel, 2001). These observations suggest
that details of LPS structure determine its ability to induce an
inflammatory response. In light of this, binding of gp12 to the
LPS molecule may affect the LPS structure sufficiently to decrease
its ability to induce immunostimulation.
Moreover, the TLR4-MD-2-LPS complex has been crystallized
and its structure has been determined at 3.1 Å resolution by
Park et al. (2009), thus revealing involvement of the whole LPS
molecule in the reaction with the mammalian receptor complex.
Binding of LPS induces the formation of a symmetrical dimer
of two TLR4-MD-2-LPS complexes. The LPS bound to MD-2
directly bridges the two TLR4 molecules. Five of the six lipid
chains in LPS are completely buried inside the MD-2 pocket,
but the sixth is partially exposed to the surface of MD-2 and
forms a hydrophobic interaction with TLR4. Hydrophilic side
chains in the surrounding regions of MD-2 and TLR4 support
the hydrophobic core of the interface by forming hydrogen
bonds and ionic interactions (Gay and Gangloff, 2007; Kim et al.,
2007; Park et al., 2009). The molecular weight of gp12 (56 kDa)
is considerable in comparison to TLR4 (approx. 95 kDa). We
hypothesize that binding of phage protein gp12 to the hydrophilic
core disturbs its function in formation of TLR4-MD-2-LPS
complexes, and may preclude a signaling pathway that could lead
to immunostimulation.
We propose interaction of the phage tail adhesin gp12 with
LPS as a potential modulator of LPS-induced inflammatory
effects. It is necessary to emphasize that sepsis or septic shock
may have different etiology. However, in many cases LPS
is the key factor triggering harmful physiological processes.
Elucidation of structure-activity correlations in LPS has
contributed to understanding of both immunostimulatory and
toxic septic processes, and it allowed for development of new
pharmacological and immunostimulatory strategies in infectious
and malignant diseases. Thus, in future studies gp12 may be
considered as a potential tool for modulation and specifically for
counteracting LPS-related physiological effects in vivo.
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